1. Simpson, G.M., Zoubok, B., Lee, H.J. An early clinical toxicity trial of EX 11–582A in chronic schizophrenia. Curr. Ther. Res., 19:87–93, 1976.
2. Abnormal Involuntary Movement Scale. HEW, Alcohol Drug Abuse and Mental Health Administration, Washington, D.C., 1974.
3. Duvoisin, R.C. Antagonism of levodopa by papaverine. JAMA, 231:845, 1975.
4. Gonzalez-Vegas, J.A. Antagonism of dopamine-mediated inhibition in the nigrostriatal pathway: a mode of action of some catatonia-inducing drugs. Brain Res., 80:219, 1974.
5. Gardos, G., Cole, J.O. Papaverine for tardive dyskinesia? N. Engl. J. Med. 292:1355, 1975.